Press Release
Finesse Solutions Showcases SmartBag with Fully Integrated Single-Use pH and pO2 Sensors for Rocker Bioreactors at Interphex
San Jose, Calif. – March 15, 2011 – Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life sciences process applications, announced a live demonstration of its new SmartBagproduct for rocker bioreactors at Interphex 2011 in New York, March 29-31.
Bioprocessing specialists will get a close-up look at the first robust single-use of the SensorPak solution that has been seamlessly integrated into a pillow bag and is resistant to gamma radiation sterilization. SmartBags are designed to be plug-and-play bio-processing containers having full measurement capability for at least 21 days.
The SmartBag SensorPak leverages TruFluor pH and dissolved oxygen phase fluorometric technology in a compact assembly that is pre-calibrated using a SmartChip and provides accurate, drift-free, in-situ measurements. The combined pH and DO optical reader uses advanced optical components including a large area photodiode that minimizes photo-degradation of the active sensing elements. The SensorPak also leverages TruFluor temperature 316L stainless steel thermal window for highly stable readings. The SensorPak is welded into the single-use vessel and eliminates the need for sterile connectors and their associated complications such as leakage and batch contamination. All wetted materials of the SensorPak are USP class VI compliant and being identical to TruFluor, allow directly measurement comparisons and scale-up from 10L rocker bags to 2,000L SUBs.
A SmartBag retrofit for the most commonly utilized rocker platform trays will be demonstrated at the show, along with the T300 labscale controller for gas and liquid management. According to Finesse Solutions CTO Dr. Mark Selker, “It is a pleasure to introduce SmartPak technology and the Smartbag to the bioprocessing market at such a major event. This product is optimized for accuracy, lifetime, and ease of use. We anticipate that the SensorPak will provide a unique, complete solution for single-use seed train bio-processing applications, which are still in great need of reliable and trustworthy key process parameter measurements.”
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications.
Media: Barbara Paldus, 408-570-9012
Finesse Solutions Introduces new T700 cGMP Upstream Processing Platform with G3 Hardware, Fully Integrated Single-Use Sensors
March 17, 2011 – Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards. Each turnkey system comprises TruViu® G3 hardware, TruBio® software, and TruFluor®/TruTorr® single-use sensors. The T700 platform brings the benefits of DeltaV reliability for cGMP applications in an affordable package, with easy scalability to multiple process trains using the DeltaV TruLogic® Controller. TruService installation, validation, and maintenance packages for the T700 platform ensure on-time, seamless commissioning validation, and reliable support.
T700 systems were optimized for use with single-use vessels that require redundant sensors and multiple peripherals. The G3 hardware system consists of a Utility Tower (holding the single-use sensor blades), a Pump Tower, and a Gas Manifold, as well as a large range of peripherals (cart, HMI, scales, third party sensors, external pumps, etc.). It is designed to minimize footprint and start-up cost. Two T700 systems can be mounted onto a cart with a NEMA 4X HMI for maximum process flexibility, or one T700 system can be mounted on bioreactor skid with integral HMI for total process mobility.
The new TruViu G3 hardware system provides a flexible yet plug-and-play solution without foregoing the robustness of industrial automation. The platform leverages next-generation TruFluor (pH and DO) blades having digital communications to the controller, and the Virtual Transmitter in TruBio software. This state-of-the art combination of hardware and software enables automated sensor calibration, full sensor diagnostics, and advanced alarming options for operators. TruBio 4.0 software enables state-of-the-art graphics, database management, calibration, alarms, report generation, OPC-interconnectivity with off-line analyzers, and real-time control algorithms. TruBio save/load files facilitate scale-up from 25L to 2,000L, and rapid, but secure technology transfer from PD into cGMP.
According to Finesse Solutions Manager of Integration and Automation, Mr. John Greenwood, “We have worked closely with our end users to define the requirements for the next generation single-use bioreactor controller. Seamless integration of single-use sensors and sensor redundancy were two key challenges to resolve. Our T700 platform allows end users to seamlessly transition from traditional to fully redundant single-use sensors. This represents a major advance in the control of single-use bioreactors.” John added, “We are looking forward to watching our T700 GMP systems deliver the competitive advantages of increased performance, long-term reliability, reduced operating costs, and greater configuration flexibility that are all enabled by our new design.”
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications.
Media: Barbara Paldus, 408-570-9012
RemoteView OPC and BatchReport Harmonizes 3rd Party Bioreactor Controllers and Analyzers with TruBio DV
March 21, 2011 – Finesse, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, has announced the official launch of two new core modules for off-line data processing in its fourth generation TruBio DV software. These modules are targeted at enabling bioprocessing specialists to manage data from third party equipment and process analyzers, and obtain automated electronic records of their batch. Since its first launch in 2007, TruBio DV continues to be powered by a DeltaV Controller from Emerson Process Management, and is fully compatible with DeltaV versions 9.3 through 11.3.
“TruBio DV software was originally developed to provide automation hardware independence and to utilize best in class components for upstream process management. TruBio DV 2.0 was optimized to enable easy scale-up and scale-down between R&D, process development, and cGMP manufacturing. TruBio DV 3.0 introduced OPC-based communication with third party analyzers such as the Nova BioProfile400 and FLEX back in 2008, and demonstrated automated feeding strategies and intelligent management of redundant process sensors for pH measurement” stated Basil Zimmo, VP of Software at Finesse.
RemoteView OPC allows seamless digital communication with third party process equipment and off-line process analyzers, so that TruBio DV can overlay on existing bioreactors to extend their useful life. BatchReport is an integrated electronic batch report generator that leverages all process data consolidated into the TruBio/DeltaV historian.
“To illustrate the power of TruBio DV 4.0 we look at existing examples: TruBio can overlay and direct over one hundred controllers from diverse manufacturers including Sartorius, Applikon, New Brunswick and DasGip, with customized cell-viabiity-based feed strategies using off-line measurements from a Nova FLEX, and simultaneously produce an electronic record comparing several bioreactors running in parallel for efficient design of experiment” summarized Mr. Zimmo.
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications.
Media: Barbara Paldus, 408-570-9012
Finesse launches MathLogic, SmartDose, and BlackBox Modules for Advanced Control wth TruBio DV 4.0 Bioprocess Software
March 22, 2011 – Finesse, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, has announced the official launch of three new core modules for advanced control in its fourth generation TruBio DV software. These modules are targeted at giving bioprocessing specialists the ability to utilize process data to create novel control strategies, facilitate sophisticated mathematical computation and logic based decision, and seamlessly utilize their own DeltaV control modules. Since its first launch in 2007, TruBio DV continues to be powered by a DeltaV Controller from Emerson Process Management, and is fully compatible with DeltaV versions 9.3 through 11.3.
“To date, TruBio DV software has integrated analog and OPC-based communication with a significant number of in-line and off-line sensors, thereby providing users with significant amounts of information about their process. Our new advanced control modules will allow users to actually use this information effectively for process characterization and optimization” stated Dr. Mark Selker, CTO at Finesse. He added, “TruBio DV 4.0 not only has significantly enhanced features for traditional sensor calibration, on-line DeltaV parameter access, and conditional alarming, but with the addition of these modules enables unique capability for both cell culture and fermentation applications.”
MathLogic provides an enhanced process parameter calculator as well as comparison and nested logic statement ability for rapidly optimizing process control campaigns. SmartDose is a new feature for liquid control that simplifies programming typical pump dosing algorithms such as bolus, ramp, and continuous feed, with or without feedback from weigh scales. BlackBoxControl unlocks TruBio for DeltaV automation experts by allowing them to program their own control modules for key process parameters such as pH, dissolved oxygen, and temperature, and then easily connect these custom modules to TruBio through a “parameter hook”.
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications.
Media: Barbara Paldus, 408-570-9012
Finesse VirtualTransmitter Module & TruFluor Transmitter Blades Seamlessly Integrate Single-Use Sensors into Bioreactor Control
March 23, 2011 – Finesse, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, has announced the official launch of the VirtualTransmitter core module for interfacing to TruFluor® pH and dissolved oxygen (DO) single-use sensors.
TruBio® DV continues to be powered by a DeltaV Controller from Emerson Process Management, and VirtualTransmitter is fully compatible with DeltaV versions 10.3 and 11.3. TruFluor pH and DO blades are offered as an option (either single or redundant) in all T700 and T300 hardware platforms. The VirtualTransmitter module is fully integrated and validated in TruBio DV 4.0 software.
The TruFluor blades are the core electronics of the regular TruFluor transmitter, but have a digital communication option enabled. They minimize both the footprint and cost of implementing single-use sensor technology. The VirtualTransmitter module allows digital communication between a controller and TruFluor transmitter blades, enabling diagnostics, alarms, and automated calibration information transfer. The VirtualTransmitter has the same look and feel as the original physical transmitter, but is operated from any HMI touchscreen. The RFID back-up system for the entering the calibration data has been replaced by the ability to download an emailed file or upload it directly from a memory stick.
“As single-use sensors become the de facto standard in bioprocessing, end users will expect them to be perfectly integrated into both the hardware and software of the control platform. VirtualTransmitter and TruFluor blades represent the next generation evolution of our single-use bioreactor control product line. Today, almost every Finesse control system shipped, even into cGMP, utilizes this technology. We expect the adoption rate of this platform to continue accelerating in the future,” stated Barbara Paldus, CEO at Finesse.
About Finesse Solutions, LLC
California-based Finesse Solutions, LLC, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing. The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer. Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications.
Media: Barbara Paldus, 408-570-9012
Finesse Introduces TruBio™ IOQ
December 4th, 2007 - Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the general release of its TruBio™IOQ package. TruBio™ IOQ is designed to take the guesswork out of validation and to complement thefully configurable TruBio™ operating system (TruBio™ OS).
Traditional validation of control systems can be expensive and time consuming, especially when new documents are created by external validation service contractors. The TruBio™ IOQ package provides all of the protocols needed to validate the maximum process configuration of a specific bioreactor type. By simply choosing the relevant sections and following the pre-written test procedures, end users can complete their installation and operational qualification.
Project managers utilizing TruBio™ IOQ can save valuable project time by eliminating the need to develop validation protocols and by minimizing the validation efforts traditionally found in implementing a new control system. With TruBio™ IOQ, customers can quickly validate TruBio™ OS functionality, minimize down time and improve predictability of the installation schedule.
Upon completing TruBio™ IOQ, users will establish documented evidence assuring that TruBio™ OS meets all user requirements and design specifications. TruBio™ IOQ provides objective evidence that TruBio™ OS performs consistently and accurately per its intended use in the bioprocess application. TruBio™ IOQ follows and incorporates established GAMP4 guidelines to ensure that TruBio™ OS is compliant with FDA’s Title 21 Code of Federal Regulations Parts 11, 210 and 211. TruBio™ IOQ also ensures that the TruBio™ OS will function as specified in cGMP and cGLP environments.
“The days of long and expensive validation are over. TruBio™ IOQ will streamline Installation and Operational Qualifications and at the same time be affordable!” says Yeng Vang, validation manager at Finesse.
About Finesse
California based Finesse leads the way in developing new measurement and control technologies,in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.
Biomedical Resources International
April 19, 2007 – Finesse Solutions, LLC, Santa Clara, CA, and Biomedical Resources International,Northborough, MA, have signed a distributor agreement for Finesses’ TrupH™, TruDO™, TruCell2™,TruTransmitter™, TruBio™ OS, TruLogic™ and TruViu™ products for the Life Science market in theNortheast from Maine to Maryland.
The combination of Biomedical Resources years of experience as a supplier of best-in class equipmentto the Life Science market and Finesse’s growing role as a manufacturer of innovative solutions forboth measurement and control in Life Science applications promises to provide end-users with theproducts and support they require to optimize their process while reducing their costs.
“We at Finesse are very pleased to have this opportunity to work with Alan and his team of industryprofessionals at Biomedical Resources. Their commitment to the Life Science industry, appreciationof the industry’s history and understanding of its forward direction is without equal,” said LarryWest, Executive V.P. Sales and Marketing Finesse.
About Finesse
California based Finesse is a global leader in process measurement and control technologies. Ourfamily of products – TruBio™, TruLogic™, TruViu™, TruCell™, TrupH™, and TruDO™, provide comprehensivesolutions for measurement and control processes in the biotech and pharmaceutical industries.
About Biomedical Resources
Biomedical Resources specializes in the Cell Culture and Fermentation marketplace where we offerthe most innovative and cutting edge technology in the BioPharmaceutical industry. In addition toour great assortment of products, Biomedical Resources maintains a staff of highly qualified andtechnical personnel as well as our own Service Department, where we will help provide the mostresponsive and outstanding support available.
Media: Kimberly Lozada, 408-327-6613
Finesse Introduces TruViu™ RDPD System
December 14th, 2007 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurementand control solutions for life sciences process applications, announced the general release of itsTruViu™ RDPD system for biotech R&D and Process Development (PD) applications. The system consists of an I/O tower and a pump tower, with an optional junction box and TruFlow™ gas manifold,namely, all the components required to control a typical R&D or PD bioreactor.
TruViu™ RDPD is designed to be flexible and modular with plug-and-play configuration, in order to maximize ease-of-use, simplify installation, and provide scheduled maintenance. The modular desig nallows TruViu™ RDPD components to be installed on, under, or above the laboratory bench, thereby permitting a significant footprint reduction and greater lab space efficiency.
TruViu™ RDPD brings the benefits of DeltaV reliability and scalability in an affordable package, and interfaces easily with the TruLogic™ Controller and TruBio™ software to deliver optimal bioreactor control.
TruViu™ RDPD also delivers the competitive advantages of increased performance, efficiency and reliability, reduced operating costs and improved ease of use. Finally, TruViu™ RDPD utilizes state of the art transmitters that enable sensor calibration algorithms and full sensor diagnostics.
“Customer response to TruViu™ RDPD has been overwhelming. They love the idea of a standard, configurable product, and now that our reliable hardware has been repackaged into an efficient footprint our biggest issue is keeping up with demand.” Said Alfy Riddle, VP Hardware.
About Finesse California based Finesse leads the way in developing new measurement and control technologies,in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries.
OPC Connectivity with Nova BioProfile 400
March 7, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and controlsolutions for life sciences process applications, and Nova Biomedical, Waltham, MA, a world leader inbiotechnology process monitoring announced the first TruBio™ OS plug-in for OPC connectivity betweenTruBio™ OS and Nova BioProfile 400, 100 Plus, Basic 4 and Basic 2 analyzers. Both companies confirmedthat a TruBio™ OS plug-in for OPC connectivity to the Nova Flex is currently in development.OPC (Openness, Productivity and Collaboration) has become the de facto standard for data exchangein process control systems. It has been adopted by the majority of the control system manufacturers inthe bioprocess industry and has proven to be a reliable method for sharing information across differenthardware platforms.
Automatic data exchange using OPC between a lab analyzer and control system reduces errors andtime delays of manual sampling, and provides automated reporting of results. It also allows the controlsystem to adjust process parameters without a 24/7 operator presence, and, in the event of processalarm conditions, alerts off-site personnel and/or takes automatic corrective action.This level of integration enables direct consolidation of off-line lab analyzer results into existing historicaldata collection, automates batch report generation, and creates a complete electronic record. Printouts ofstandalone analyzer results do not have to be manually attached or tracked with electronic batch reportsthat control systems already provide.
“Taking advantage of OPC connectivity between Nova analyzers and the Finesse bioprocess controlsystem will improve quality and yield, while reducing operating costs. For example, programming a Novaanalyzer to automatically standardize an in-situ probe, or using the resulting sample data in real-timecontrol algorithms, will increase both process understanding and control accuracy,” stated Dr. MarkSelker, CTO and co-founder of Finesse.
“By redefining the standard associated with offline data to include complete integration and the value ofthose data as they are applied to the bioprocess automatically, Nova and Finesse continue to provide thecutting edge technology required to bring the biotechnology industry into a new era of effectiveness andprofitability. The value lies in the actions upon that information. Nova and Finesse provide the complimentto each other’s technologies thereby allowing our customers real-time benefits that, until now, wereimpossible.” says Bob Fox, Director of Sales.
About Finesse Solutions, LLCCalifornia-based Finesse Solutions, LLC, leads the way in developing new measurement and controltechnologies, in order to enable the transition to single-use systems, bring new capabilities to existingbioreactor platforms, and harmonize global bio-process information transfer. Our current product familyprovides comprehensive measurement and control solutions for upstream processes in the biotechand pharmaceutical industries. For more information, please visit us at www.finesse.com.
About Nova BiomedicalNova Biomedical is committed to continue its technology leadership with advanced products that providebetter, faster diagnostic information. We continue to innovate biotechnology instruments that allow faster,more economical development of drugs and other therapeutic products.
John O’Connell Joins Finesse Solutions as VP of Sales and Business Development
February 22, 2008 – Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement andcontrol solutions for life sciences process applications, announced the appointment of John O’Connellas its Vice-President of Sales and Business Development. Mr. O’Connell is a seasoned executive withover 25 years of experience in the automation industry. John was most recently at OSIsoft where hesuccessfully initiated partner programs for strategic customers in the life sciences and power industries.Prior to joining OSIsoft, Mr. O’Connell was a partner at Technology 2 Market a sales and marketingconsulting firm, and held executive positions at Krohne Inc. a leading manufacturer of flow and levelmeasurement systems.
At Finesse Solutions, Mr. O’Connell will be responsible for worldwide sales of sensor and automationsystems products. Mr. O’Connell said, “I am extremely excited to join Finesse, as I believe the companyhas a tremendous opportunity to solve many real-world problems in life science measurement andcontrol applications.”
According to Finesse Solutions CEO Dr. Barbara Paldus, “We are experiencing significant growth asour products are gaining acceptance in the life science industry. We are extremely pleased to havesomeone of John’s caliber join our company, in order to guide the sales organization to meet ouraggressive objectives.”
About FinesseCalifornia-based Finesse Solutions, LLC, leads the way in developing new measurement and controltechnologies, in order to enable the transition to single-use systems, bring new capabilities to existingbioreactor platforms, and harmonize global bio-process information transfer. Our current product familyprovides comprehensive measurement and control solutions for upstream processes in the biotechand pharmaceutical industries.

